• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Astec Share Price

    Astec Lifesciences Share PriceAstec Lifesciences

    Small Cap 3.2k Result
    ₹1342.1
    17.7 (1.34%)
    • Advice
    • Hold
    As on 23 September, 2023 | 00:54 BSE: 533138 NSE: ASTECISIN: INE563J01010

    Astec Lifesciences Performance

    Day Range

    • Low 1305
    • High 1366
    1342.1

    52 Week Range

    • Low 1045
    • High 2288.8
    1342.1
    • Open Price1330
    • Previous Close1324.4
    • Volume12857

    Start SIP in Astec Lifesciences

    Start SIP

    Astec Lifesciences Share Price

    • Over 1 Month -0.37%
    • Over 3 Month -1.01%
    • Over 6 Month 11.17%
    • Over 1 Year -29.19%

    Astec Lifesciences Key Statistics

    P/E Ratio 440.8
    PEG Ratio -4.7
    Market Cap Cr 2,632
    Price to Book Ratio 6.3
    EPS 13.2
    Dividend 0.1
    Relative Strength Index 45.44
    Money Flow Index 32.73
    MACD Signal 12.01
    Average True Range 46.31

    Astec Lifesciences Investment Rating

    • Master Rating:

    • Astec Lifesciences has an operating revenue of Rs. 586.75 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 6% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 139 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Astec Lifesciences Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 143127117200184272
    Operating Expenses Qtr Cr 140122105166159207
    Operating Profit Qtr Cr 3512332565
    Depreciation Qtr Cr 9898911
    Interest Qtr Cr 666543
    Tax Qtr Cr -3-106415
    Net Profit Qtr Cr -8-51181143
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 641687
    Operating Expenses Annual Cr 552522
    Operating Profit Annual in Cr 76154
    Depreciation Cr 3434
    Interest Annual Cr 219
    Tax Annual Cr 931
    Net Profit Annual Cr 2690
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 7423
    Cash from Investing Activity Annual Cr -112-104
    Cash from Financing Annual Activity Cr 3880
    Net Cash Flow Annual Cr 00
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 419396
    Fixed Assets Annual Cr 445363
    Total Non Current Assets Annual Cr 481379
    Total Current Assets Annual Cr 498518
    Total Assets Annual Cr 979897
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 214202
    ROE Annual % 623
    ROCE Annual % 1232
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1424
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 143127117200184272
    Operating Expenses Qtr Cr 140122105166159207
    Operating Profit Qtr Cr 3512332565
    Depreciation Qtr Cr 9898911
    Interest Qtr Cr 666543
    Tax Qtr Cr -3-106415
    Net Profit Qtr Cr -8-51181143
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 641687
    Operating Expenses Annual Cr 552522
    Operating Profit Annual in Cr 76154
    Depreciation Cr 3434
    Interest Annual Cr 219
    Tax Annual Cr 931
    Net Profit Annual Cr 2690
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 7524
    Cash from Investing Activity Annual Cr -113-104
    Cash from Financing Annual Activity Cr 3880
    Net Cash Flow Annual Cr 00
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 419396
    Fixed Assets Annual Cr 445363
    Total Non Current Assets Annual Cr 481381
    Total Current Assets Annual Cr 499516
    Total Assets Annual Cr 979897
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 214202
    ROE Annual % 623
    ROCE Annual % 1232
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1424

    Astec Lifesciences Technicals

    EMA & SMA

    Current Price
    ₹1342.1
    17.7 (1.34%)
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹1367.05
    • 50 Day
    • ₹1356.05
    • 100 Day
    • ₹1372.06
    • 200 Day
    • ₹1447.21
    • 20 Day
    • ₹1383.56
    • 50 Day
    • ₹1333.93
    • 100 Day
    • ₹1359.97
    • 200 Day
    • ₹1429.91

    Astec Lifesciences Resistance and Support

    PIVOT
    ₹1337.7
    Resistance
    First Resistance ₹1370.4
    Second Resistance ₹1398.7
    Third Resistance ₹1431.4
    RSI 45.44
    MFI 32.73
    MACD Single Line 12.01
    MACD 1.35
    Support
    First Resistance ₹1309.41
    Second Resistance ₹1276.7
    Third Resistance ₹1248.41

    Astec Lifesciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 13,931 736,393 52.86
    Week 9,052 496,154 54.81
    1 Month 17,279 877,783 50.8
    6 Month 42,883 1,404,847 32.76

    Astec Lifesciences Result Highlights

    Astec Lifesciences Synopsis

    NSE-Chemicals-Agricultural

    Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 628.17 Cr. and Equity Capital is Rs. 19.61 Cr. for the Year ended 31/03/2023. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.
    Market Cap 2,632
    Sales 587
    Shares in Float 0.65
    No of funds 35
    Yield 0.11
    Book Value 6.27
    U/D Vol ratio 2.1
    LTDebt / Equity 3
    Alpha -0.16
    Beta 0.77

    Astec Lifesciences

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 66.76%66.77%66.77%66.77%
    Mutual Funds 9.14%9.57%8.45%8.71%
    Foreign Portfolio Investors 1.95%2.29%2.19%1.53%
    Financial Institutions/ Banks
    Individual Investors 17.75%16.81%17.86%18.02%
    Others 4.4%4.56%4.73%4.97%

    Astec Lifesciences Management

    Name Designation
    Mr. Nadir B Godrej Chairman
    Mr. Ashok V Hiremath Non Executive Director
    Mr. Balram Singh Yadav Non Executive Director
    Mr. Anurag Roy WholeTime Director & CEO
    Dr. Brahma Nand Vyas Independent Director
    Mr. Vijay Kashinath Khot Independent Director
    Mr. R R Govindan Independent Director
    Mr. Nandkumar Dhekne Independent Director
    Ms. Anjali Gupte Independent Director
    Mr. Burjis Nadir Godrej Non Executive Director

    Astec Lifesciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Astec Lifesciences Corporate Action

    Date Purpose Remarks
    2023-07-27 Quarterly Results
    2023-05-02 Audited Results & Final Dividend
    2023-01-30 Quarterly Results & Others Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. per share(15%)Final Dividend
    2022-10-28 Quarterly Results
    2022-07-25 Quarterly Results

    Astec Lifesciences MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 36540
    Nippon India Multi Cap Fund - Growth 20192
    ICICI Prudential Multicap Fund Growth 8564
    ICICI Prudential Smallcap Fund Growth 6989
    ICICI Prudential MidCap Fund Growth 4317
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Astec Lifesciences FAQs

    What is Share Price of Astec Lifesciences ?

    Astec Lifesciences share price is ₹1342 As on 23 September, 2023 | 00:40

    What is the Market Cap of Astec Lifesciences ?

    The Market Cap of Astec Lifesciences is ₹2631.8 Cr As on 23 September, 2023 | 00:40

    What is the P/E ratio of Astec Lifesciences ?

    The P/E ratio of Astec Lifesciences is 440.8 As on 23 September, 2023 | 00:40

    What is the PB ratio of Astec Lifesciences ?

    The PB ratio of Astec Lifesciences is 6.3 As on 23 September, 2023 | 00:40

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Enter Mobile Number

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.